Navigation Links
Westlake Chemical Increases Quarterly Dividend By Over 150%
Date:8/20/2012

HOUSTON, Aug. 20, 2012 /PRNewswire/ -- The board of directors of Westlake Chemical Corporation (NYSE: WLK) declared on Friday a dividend of 18.75 cents per share, an increase of over 150% from the 7.375 cents per share paid in the second quarter of 2012. The increased dividend will be payable on September 12, 2012, to stockholders of record on August 30, 2012.

This is the 32nd successive quarterly dividend that Westlake has declared since completing its initial public offering in August 2004.

Westlake Chemical Corporation (WLK)

Westlake Chemical Corporation is an international manufacturer and supplier of petrochemicals, polymers and building products with headquarters in Houston, Texas. The company's range of products includes: ethylene, polyethylene, styrene, propylene, caustic, VCM, PVC resin and PVC building products including PVC pipe, windows and fence. For more information, including career opportunities, visit the company's website at http://www.westlake.com.


'/>"/>
SOURCE Westlake Chemical Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology news :

1. Hearing the telltale sounds of dangerous chemicals
2. Predatory beetles eavesdrop on ants chemical conversations to find best egg-laying sites
3. Chemistry on Mars video with Curiosity Rover from the American Chemical Society
4. Hormone-mimicking chemicals cause inter-species mating
5. Hunting for autisms chemical clues
6. Synthetic diamond steps closer to next generation of high performance electrochemical applications
7. Chemical fingerprinting tracks the travels of little brown bats
8. The first chemical circuit developed
9. Production of chemicals without petroleum
10. Trial launched into curry chemicals cancer-fighting properties
11. Chemical engineers at UMass Amherst find high-yield method of making xylene from biomass
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 2017  In vitro diagnostic (IVD) companies were very ... (M&A), and Kalorama Information expects that trend to continue ... shifting. Generally, uncertainty in reimbursement and healthcare reform in ... changed the acquisitions landscape. Instead of looking to buy ... partners outside of their home country and also to ...
(Date:1/12/2017)... Jan. 12, 2017  New research undertaken by Fit ... the future.  1,000 participants were simply asked which office technology ... we may consider standard issue.  Insights on what will ... also gathered from futurists and industry leaders including Penelope ... Canton .  Some of these findings ...
(Date:1/6/2017)... Calif. , Jan. 6, 2017  Privately-held ... safety studies in healthy volunteers of a novel ... to treat acute pancreatitis. Acute ... typically a mild disorder, but can be very ... failure and sepsis, where extended hospital stays, time ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... Malden, MA (PRWEB) , ... January 18, 2017 ... ... announced today that Dr. Dante Leven successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation ... Medical Center in Valley Stream, NY. The procedure was an anterior cervical discectomy ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... and paralysis, today announced that it has submitted a 510(k) to the FDA, ... that utilize MYOLYN’s patent-pending functional electrical stimulation (FES) technology. , The submission ...
(Date:1/18/2017)... Chicago, IL (PRWEB) , ... January 18, 2017 ... ... auction on January 24th, 2017, to sell research and genetic testing lab equipment ... of service in the Northwest and Northeast regions of the United States. This ...
(Date:1/18/2017)... Shareholder rights law firm Johnson & Weaver, ... members of CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD ... proposed sale of the Company to Eli Lilly and ... molecules for the acute treatment of migraines. ... a definitive merger agreement with Eli Lilly. Under the ...
Breaking Biology Technology: